1-(2,3-Dihydrofuro[3,2-h]quinolin-2-yl)-2,2-dimethyl-1-propanone (3a). 1,1,3,3-Tetramethylguani-
dine (0.52 ml, 0.47 g, 4.1 mmol) was added to a mixture of 8-hydroxy-7-piperidinomethylquinoline (1) [15]
(1.00 g, 4.1 mmol) and 1-(3,3-dimethyl-2-oxobutyl)pyridinium bromide (2a) [16] (1.06 g, 4.1 mmol) in MeCN
(15 ml). The solution obtained was refluxed for 5 h under an argon atmosphere. The solvent was evaporated in
vacuo, the residue was treated with MeOH (5 ml), and the mixture was held for 1 day at -20ºC. The precipitate
was filtered off, washed with cold MeOH, and recrystallized from EtOH. Yield 0.44 g (42%). Colorless crystals,
mp 112-113ºC. IR spectrum, , cm-1: 2974, 2951, 2866, 1717(C=O), 1512, 1462, 1396, 1362, 1315, 1288, 1080,
930, 837, 783. 1H NMR spectrum, , ppm (J, Hz): 1.27 (9H, s, C(CH3)3); 3.47 (1H, dd, 2J = 15.6, 3J = 7.8) and
2
3
3
3
3.59 (1H, dd, J = 15.6, J = 10.5, CH2); 5.73 (1H, dd, J = 10.5, J = 7.3, CH); 7. 28-7.31 (3H, m, H-4,5,7);
3
4
3
4
13
8.05 (1H, dd, J = 8.2, J = 1.4, H-6); 8.82 (1H, dd, J = 4.1, J = 1.4, H-8). C NMR spectrum, , ppm: 26.2
(CH3); 34.7 (CH2); 43.8 (C); 82.1 (CH); 120.6 (CH); 121.1 (CH); 123.2 (C); 123.2 (CH); 129.0 (C); 135.8 (C);
136.0 (CH); 150.0 (CH); 154.5 (C); 211.4 (C=O). Mass spectrum, m/z (Irel, %): 255 [M]+ (7), 198 [M-C(CH3)3]+
(15), 170 [M-(CH3)3CCO]+ (100), 142 (33), 115 (8), 57 [C(CH3)3]+ (13). Found, %: С 75.35; Н 6.77; N 5.41.
C16H17NO2. Calculated, %: C 75.27; H 6.71; 5.49.
1-Adamantyl-2,3-dihydrofuro[3,2-h]quinolin-2-ylmethanone (3b) was prepared similarly to
compound 3a from compound 1 (1.00 g, 4.1 mmol), 1-[2-(1-adamantyl)-2-oxoethyl]pyridinium bromide (2b)
[17] (1.39 g, 4.1 mmol), and 1,1,3,3-tetramethylguanidine (0.52 ml, 0.47 g, 4.1 mmol). Yield 0.76 g (55%).
Colorless crystals, mp 174-175ºC (EtOH). IR spectrum, , cm-1: 2901, 2851 (CHAd); 1705 (C=O), 1512, 1466,
1362, 1312, 1285, 1165, 1080, 1011, 922, 829. 1H NMR spectrum, , ppm (J, Hz): 1.69-1.76 (6H, m, CH2 Ad);
2
3
1.90-1.98 (6H, m, CH2 Ad); 2.05 (3H, br. s, CH Ad); 3.42 (1H, dd, J = 15.6, J = 7.6) and 3.57 (1H, dd,
3
3
3
2J = 15.6, J = 10.5, CH2); 5.77 (1H, dd, J = 10.5, J = 7.6, CH); 7.26-7.30 (3H, m, H-4,5,7); 8.06 (1H, dd,
3J = 8.2, J = 1.4, H-6); 8.82 (1H, dd, J = 4.1, J = 1.4, H-8). 13C NMR spectrum, , ppm: 27.8 (CH); 34.6
(CH2); 36.5 (CH2); 37.8 (CH2); 45.9 (C); 81.1 (CH); 120.5 (CH); 121.1 (CH); 123.0 (C); 123.2 (CH); 129.0 (C);
135.8 (C); 136.0 (CH); 150.0 (CH); 154.7 (C); 210.0 (C=O). Mass spectrum, m/z (Irel, %): 333 [M]+ (5), 198
[M-Ad]+ (22), 197 [M-H-Ad]+ (15), 170 [M-AdCO]+ (100), 169 [M-AdCO-H]+ (40), 142 (25), 135 [Ad]+ (90).
Found, %: С 79.16; Н 7.02; N 4.26. C22H23NO2. Calculated, %: C 79.25; H 6.95; N 4.20.
4
3
4
Cyclopropyl-2,3-dihydrofuro[3,2-h]quinolin-2-ylmethanone (3c) was prepared similarly to
compound 3a from compound 1 (1.00 g, 4.1 mmol), 1-(2-cyclopropyl-2-oxoethyl)pyridinium bromide 2c [18]
(1.00 g, 4.1 mmol), and 1,1,3,3-tetramethylguanidine (0.52 ml, 0.47 g, 4.1 mmol). Yield 0.34 g (34%).
Colorless crystals, mp 80-82ºC (Et2O). IR spectrum, , cm-1: 3005, 2920, 1701 (C=O), 1512, 1466, 1389, 1362,
1
1319, 1288, 1122, 1076, 972, 945, 829, 791. H NMR spectrum, , ppm (J, Hz): 0.90-0.96 (1H, m,
cyclopropyl); 1.00-1.18 (3H, m, cyclopropyl); 2.63-2.69 (1H, m, cyclopropyl); 3.60 (1H, dd, 2J = 16.0, 3J = 7.4)
2
3
and 3.70 (1H, dd, J = 16.0, J = 11.0, CH2); 5.43 (1H, dd, 3J = 11.0, 3J = 7.4, CH); 7.36-7.40 (3H, m, H-4,5,7);
4
3
4
8.14 (1H, dd, 3J = 8.2, J = 1.8, H-6); 8.89 (1H, dd, J = 4.6, J = 1.8, H-8). 13C NMR spectrum, , ppm: 12.6
(CH2); 13.0 (CH2); 16.7 (CH); 34.2 (CH2); 86.9 (CH); 120.9 (CH); 121.2 (CH); 123.4 (CH); 123.6 (C); 129.0
(C); 135.9 (C); 136.2 (CH); 150.2 (CH); 154.3 (C); 210.4 (C=O). Mass spectrum, m/z (Irel, %): 239 [M]+ (4),
198 [M-C3H5]+ (1), 170 [M-C3H5CO]+ (100), 142 (26), 115 (9), 69 [C3H5CO]+ (5). Found, %: С 75.39; Н 5.54;
N 5.76. C15H13NO2. Calculated, %: C 75.30; H 5.48; N 5.85.
4-Bromophenylfuro[3,2-h]quinolin-2-ylmethanone (4). 1,1,3,3-Tetramethylguanidine (0.52 ml,
0.47 g, 4.1 mmol) was added to a mixture of compound 1 (1.00 g, 4.1 mmol), 1-[2-(4-bromophenyl)-2-oxo-
ethyl]pyridinium bromide 2d [19] (1.47 g, 4.1 mmol) in MeCN (20 ml), and the solution obtained was refluxed
for 10 h with vigorous stirring in the presence of atmospheric oxygen. Solvent was evaporated in vacuo, and the
residue was treated with cold MeOH (5 ml) and held at -20ºC for 1 day. The precipitate was filtered off, washed
with cold MeOH, and recrystallized from EtOH. Yield 0.51 g (35%). Pale-yellow crystals, mp 167-168ºC. IR
spectrum, , cm-1: 3082, 2924, 1639 (C=O), 1582, 1539, 1508, 1373, 1323, 1300, 1119, 968, 899, 829, 752. 1H
NMR spectrum, , ppm (J, Hz): 7.50 (1H, dd, 3J = 8.2, 3J = 4.4, H-7); 7.65 (1H, d, 3J = 8.5, H-5); 7.67 (2H, d,
3
3
3J = 8.7, H-3',5'); 7.73 (1H, s, H-3); 7.75 (1H, d, J = 8.5, H-4); 8.06 (2H, d, J = 8.7, H-2',6'); 8.23 (1H, dd,
3J = 8.2, J = 1.6, H-6); 9.00 (1H, dd, J = 4.4, J = 1.6, H-8). 13C NMR spectrum, , ppm: 116.5 (CH); 121.2
4
3
4
995